DDIAX
Price
$16.05
Change
+$0.06 (+0.38%)
Updated
Oct 17 closing price
Net Assets
836.81M
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

DDIAX vs RLBEX

Header iconDDIAX vs RLBEX Comparison
Open Charts DDIAX vs RLBEXBanner chart's image
Macquarie Wealth Builder A
Price$16.05
Change+$0.06 (+0.38%)
VolumeN/A
Net Assets836.81M
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
DDIAX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
DDIAX vs. RLBEX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDIAX is a Hold and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 265B vs. DDIAX (837M). RLBEX pays higher dividends than DDIAX: RLBEX (1.74) vs DDIAX (1.50). DDIAX was incepted earlier than RLBEX: DDIAX (29 years) vs RLBEX (23 years). DDIAX (1.09) is less costly to investors than RLBEX (0.59). DDIAX is a more actively managed with annual turnover of: 66.00 vs. RLBEX (44.00). RLBEX has a lower initial minimum investment than DDIAX: RLBEX (250) vs DDIAX (1000). RLBEX annual gain was more profitable for investors over the last year : 8.70 vs. DDIAX (3.42). RLBEX return over 5 years is better than : 42.04 vs. DDIAX (31.33).
DDIAXRLBEXDDIAX / RLBEX
Total Expense Ratio1.060.59180%
Annual Report Gross Expense Ratio1.090.59185%
Fund Existence29 years23 years-
Gain YTD10.38914.63171%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets837M265B0%
Annual Yield % from dividends1.501.7486%
Returns for 1 year3.428.7039%
Returns for 3 years27.1350.5254%
Returns for 5 years31.3342.0475%
Returns for 10 years42.0077.6954%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRSX2.280.11
+4.88%
Foresight Autonomous Holdings Ltd
USFD76.121.17
+1.56%
US Foods Holding Corp
NTLA24.75-0.16
-0.64%
Intellia Therapeutics
NAGE7.33-0.09
-1.21%
Niagen Bioscience Inc
LFVN8.81-0.16
-1.78%
Lifevantage Corp